Search Results - "Datnow B"

Learning Personalized Treatment Strategies with Predictive and Prognostic Covariates in Adaptive Clinical Trials.

Authors: Alban, Andres Chick, Stephen E. Zoumpoulis, Spyros I.

Source: Management Science (INFORMS). Jul2026, Vol. 72 Issue 7, p5943-5962. 20p.

Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment.

Authors: Shang, Qingyao Lin, Zian Plichta, Jennifer et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p989. 13p.

Extra-Appendiceal Neuroendocrine Expressing Goblet Cell Adenocarcinoma of the Cecum—A Case Report and Brief Review of the Literature.

Authors: Dinu, Alexandra Aşchie, Mariana Bălţătescu, Gabriela Isabela et al.

Source: Reports (MDPI AG). Mar2025, Vol. 8 Issue 1, p1. 14p.

Correlation Study Between Neoadjuvant Chemotherapy Response and Long-Term Prognosis in Breast Cancer Based on Deep Learning Models.

Authors: Wang, Ke Luo, Yikai Zhang, Peng et al.

Source: Diagnostics (2075-4418). Nov2025, Vol. 15 Issue 21, p2763. 12p.

Accurate Co-Localization of Luciferase Expression and Fluorescent Anti-CEA Antibody Targeting of Liver Metastases in an Orthotopic Mouse Model of Colon Cancer.

Authors: Lee, Kyung-Ha Cox, Kristin E. Amirfakhri, Siamak et al.

Source: Cancers. Oct2024, Vol. 16 Issue 19, p3341. 12p.

Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study.

Authors: Canino, Fabio Barbolini, Monica De Giorgi, Ugo et al.

Source: BMC Cancer. 6/15/2024, Vol. 24 Issue 1, p1-18. 18p.

Clinical prediction of pathological complete response in breast cancer: a machine learning study.

Authors: He, Chongwu Yu, Tenghua Yang, Liu et al.

Source: BMC Cancer. 5/23/2025, Vol. 25 Issue 1, p1-12. 12p.

Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study.

Authors: Gori, Stefania Fabi, Alessandra Angiolini, Catia et al.

Source: Cancers. Oct2023, Vol. 15 Issue 19, p4852. 16p.

Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer.

Authors: Guan, Feng Ju, Xianli Chen, Lixia et al.

Source: Diagnostic Pathology. 9/30/2024, Vol. 19 Issue 1, p1-14. 14p.

Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Node‐Positive HR+, HER2− Breast Cancer (Nodal pCR and the Rate of ALND): A Systematic Review and Meta‐Analysis.

Authors: Vasigh, Mahtab Karoobi, Mohammadreza Williams, Austin D. et al.

Source: Breast Journal. 8/1/2024, Vol. 2024, p1-12. 12p.

Discrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers.

Authors: Nikas, Ilias P. Lim, Sojung Im, Seock-Ah et al.

Source: Pathobiology. 2024, Vol. 91 Issue 3, p169-179. 11p.

Multi-omic-based classification for identifying optimal neoadjuvant treatment strategies for high-risk early-stage breast cancer.

Authors: Ji F Chen X Yang C et al.

Source: Science China. Life sciences [Sci China Life Sci] 2025 Oct; Vol. 68 (10), pp. 2934-2949. Date of Electronic Publication: 2025 Jul 24.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Science China Press, co-published with Springer Country of Publication: China NLM ID: 101529880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1869-1889 (Electronic) Linking ISSN: 16747305 NLM ISO Abbreviation: Sci China Life Sci Subsets: MEDLINE

Involvement of nucleic acid-sensing toll-like receptors in human diseases and their controlling mechanisms.

Authors: Lin, You-Sheng Chang, Yung-Chi Pu, Tzu-Yu et al.

Source: Journal of Biomedical Science. 6/10/2025, Vol. 32 Issue 1, p1-28. 28p.

HER2 discordance between primary and metastatic gastric cancer: a systematic review and meta-analysis.

Authors: Moraes FCA Rego LHRM Rebelo TG et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May 12. Date of Electronic Publication: 2026 May 12.

Publication Type: Journal Article

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Integrins as Key Mediators of Metastasis.

Authors: Cáceres-Calle, Daniel Torre-Cea, Irene Marcos-Zazo, Laura et al.

Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 3, p904. 24p.

Comprehensive Review of Metastatic Breast Carcinoma in Cytology Specimens.

Authors: Baskota, Swikrity U. Qazi, Daniel Chandra, Ashish et al.

Source: Journal of Molecular Pathology. Dec2022, Vol. 3 Issue 4, p293-306. 14p.

Immunohistochemistry Applied to Breast Cytological Material.

Authors: Pinto, Daniel Schmitt, Fernando C.

Source: Pathobiology. 2022, Vol. 89 Issue 5, p343-358. 16p.

Shifting the Paradigm: The Transformative Role of Neoadjuvant Therapy in Early Breast Cancer.

Authors: Hirmas, Nader Holtschmidt, Johannes Loibl, Sibylle

Source: Cancers. Sep2024, Vol. 16 Issue 18, p3236. 31p.

Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma.

Authors: Wang, Bo Li, Mengyan Su, Anna et al.

Source: Analytical Cellular Pathology: Cellular Oncology. 8/31/2022, p1-16. 16p.

Pathologic Complete Response and Its Impact on Breast Cancer Recurrence and Patient's Survival after Neoadjuvant Therapy: A Comprehensive Meta-Analysis.

Authors: Liu, Hui Lv, Liqiong Gao, Hui et al.

Source: Computational & Mathematical Methods in Medicine. 12/31/2021, Vol. 2021, p1-11. 11p.